Health Economic Value of Blood in Kenya, Ghana and Ivory Coast: The Case of Maternal Bleeding
Background: In sub-Saharan Africa, severe bleeding accounts for up to 44% of maternal deaths, and the need for blood products far outstrips supply.
Aims and objectives: We aimed to map the causes and consequences of blood shortage in Kenya, Ghana and Ivory Coast and estimate the health economic impact of overcoming blood shortages resulting in maternal bleeding.
Methods: We conducted a targeted literature review to evaluate the impact of blood shortage on maternal mortality rates due to post-partum haemorrhage (PPH). Clinical experts from the selected countries were included as an additional source of information. Using a de novo budget impact model, costs associated with severe maternal bleeding were compared with investment costs to adequately manage maternal bleeding.
Results: Of the estimated 4 000 941 births/year, 118 428 will be confronted with severe PPH requiring blood transfusion. The estimated total yearly value of life years lost for the three countries combined would be 57 104 042 USD. The total cost to provide adequate blood supply (13 units/patient) was 33 781 945 USD, meaning that blood transfusion in PPH results in 23 322 097 USD saved with savings starting from the first year onwards in Kenya and Ghana, and from the second year onwards in Ivory Coast.
Conclusion: In Kenya, Ghana and Ivory Coast, an increased investment in blood supply would likely provide large cost savings in less than two years.